3 ML insulin glargine-aglr 100 UNT/ML Pen Injector [Rezvoglar]
RxNorm concept 2589014, branded drug (sbd). Prescribable name: REZVOGLAR (insulin glargine-aglr) 100 UNT/ML in 3 ML Pen Injector.
- RxCUI
- 2589014
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2589014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
3 ML Rezvoglar 100 UNT/ML Pen Injector; Rezvoglar KwikPen (insulin glargine-aglr) 300 UNT per 3 ML Pen Injector
Related concepts
- insulin glargine-aglr 100 UNT/ML (SCDC, consists of)
- insulin glargine-aglr 100 UNT/ML [Rezvoglar] (SBDC, consists of)
- Pen Injector (DF, has dose form)
- Rezvoglar (BN, has ingredient)
- 3 ML insulin glargine-aglr 100 UNT/ML Pen Injector (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2589014 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2589014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2589014. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.